Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02083380Phase 3Completed
A Phase 3 trial of artefenomel in Plasmodium falciparum malaria, sponsored by Medicines for Malaria Venture. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02083380.